Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib price?Is allopurinol expensive?Patent tenofovir alafenamide gilead?Drugpatentwatch skyrizi biologic patent analysis?Quartette side effects?
See the DrugPatentWatch profile for Vyvanse
Vyvanse is lisdexamfetamine dimesylate, a prodrug of dextroamphetamine. In the United States, there are no widely marketed generic versions of lisdexamfetamine dimesylate available on the market as of my latest update. Vyvanse (brand) is marketed by Takeda. Some generic lisdexamfetamine products have been approved or cleared in the past, but they may not be launched yet due to patent or exclusivity issues. If you’re asking about a country outside the U.S., generics may be available there from different manufacturers. How to check current status: - In the U.S.: search the FDA’s Orange Book (Drugs@FDA) for lisdexamfetamine dimesylate to see current generic approvals and patent/exclusivity status. - Ask your pharmacist or doctor for the exact generic strength/formulation you need (e.g., 10 mg, 20 mg capsules) and the current manufacturer if a generic is available in your area. If you’d like, tell me your country or region and I can tailor the information to that market. I can also help you check the most up-to-date status if you want me to look it up.
Other Questions About Vyvanse :